ABL Market Share Analysis for May 2026

abl conquers today’s most challenging diseases through developing our clients novel gene therapies, vaccines, oncolytics and immunotherapies.

Health > Biotechnology and Pharmaceuticals

Domainablinc.com

Year Founded1961

Employees51 - 200

Annual Revenue$50M - $75M

ABL

ABL (including company regionals)

ablinc.com

See more website traffic and engagement information

ABL Revenue up to May 2026 is 50M - 75M

revenue generated by ABL top domains

ABL top domains revenue over 3 years

Revenue for ABL top domains

ablinc.com50M - 75M

See more with Sales Intelligence

Total visits to ABL's top domains

Understand ABL market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ablinc.com5.2K

See more with Sales Intelligence

Avg. visit duration in ABL's top domains

Analyze ABL engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ablinc.com00:00:10

See more with Sales Intelligence

Avg. pageviews on ABL's top domains

See how ABL keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ablinc.com1.73

See more with Sales Intelligence

ABL top competitors by domain

Top similar sites in May 2026, ranked by their affinity

biosciencelabs.comCompany NameBioScience Laboratories, Inc.Employees51 - 200HQUnited States, Montana, BozemanAnnual revenue$15M - $25MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by ABL

These are the website technologies, by industry, used by ABL top domains

Widget (9)

Twemoji

Payment & Currencies (6)

Cart Functionality

Advertising (4)

DoubleClick

Email Services (4)

G Suite

More Technologies

11

See all

News & Signals from ABL

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAdvanced BioScience Laboratories, Inc. merged with Ascend Ltd. on Nov 1st '24.In November 2024, ABL merged with Ascend Advanced Therapies, a CDMO with clinical AAV manufacturing experience going back to 1991.

NewsAdvanced BioScience Laboratories, Inc. hires Erika Wachs as Director of Business Development.Erika Wachs appointed Director of Business Development at ABL, Inc.